Identifying High-Risk NASH Patients: What We Know so Far
Marten Schulz, Frank Tacke Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) Und Campus Charité Mitte (CCM), Berlin, GermanyCorrespondence: Marten Schulz Email marten.schulz@charite.deAbstract: Steatosis is...
Guardado en:
Autores principales: | Schulz M, Tacke F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ad489856c48403ba962900db6201b89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
por: Serra JT, et al.
Publicado: (2020) -
Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
por: Ahmed Z, et al.
Publicado: (2018) -
A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli S, et al.
Publicado: (2019) -
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?
por: Dajti E, et al.
Publicado: (2021) -
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
por: Philippe Garteiser, et al.
Publicado: (2021)